Caris Life Sciences this week named Ian Walker vice president of strategic marketing for Europe and Ian Abercrombie vice president of commercial operations for Europe. The new positions "reflect the company's rapid scaling for an aggressive growth strategy in the region," it said.
Previously Abercrombie was European director of oncology at Genzyme and the program director at UK-based start-up Bioenvision. Walker was most recently global programming director of molecular diagnostics for Novartis.
Stefan Gruenwald was appointed this week to the scientific advisory board of Fibrocell Science, a biotech company focusing on the development of autologous cell therapies.
Gruenwald is the co-founder of San Diego-based proteomics firm Orbigen, which merged in 2004 with Biocarta and Chinese biotech reagent company Jingmei.